Hylur Eye Drop contains Flurbiprofen 0.03% w/v, a nonsteroidal anti-inflammatory drug (NSAID) indicated for the management of ocular inflammation and pain. Flurbiprofen acts by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins involved in inflammatory processes. This ophthalmic solution is primarily used to prevent miosis during intraocular surgery and to alleviate postoperative inflammation. It is also effective in reducing pain and discomfort associated with ocular procedures or conditions characterized by inflammation. Hylur Eye Drop should be administered as directed by a healthcare professional, typically instilled into the conjunctival sac at specified intervals before and after surgery or as needed for inflammation control. Patients should avoid contact lens use during treatment unless advised otherwise. Common adverse effects may include transient burning or stinging upon instillation, conjunctival hyperemia, and occasional blurred vision. It is contraindicated in individuals with hypersensitivity to Flurbiprofen or other NSAIDs and should be used cautiously in patients with a history of corneal epithelial defects or impaired healing. Proper aseptic technique is essential to prevent contamination. Hylur Eye Drop offers a targeted approach to ocular inflammation, enhancing patient comfort and surgical outcomes.